Skip to main content
. 2022 Sep 12;9:82–90. doi: 10.33393/grhta.2022.2449

Table S4.

Percentage use of screening techniques

Percentage use
Fluorescent “in situ” hybridization (FISH) 11.63%
Immunohistochemistry (IHQ) 37.21%
IHQ+FISH 46.51%
Next Generation Sequencing (NGS) 4.65%

Reference: (4)